Getting Started with AI-Powered HALO Image Analysis
23 April 2026 | Learn how HALO and HALO AI enable quantitative image analysis, turning complex tissue data into actionable insights
Getting Started with AI-Powered HALO Image Analysis Read More »
News
KLAS Recognition as a Catalyst for What Comes Next
We are proud to mark a significant milestone: HALO AP® earned the highest overall customer rating in the 2026 KLAS Global Software report for digital pathology. Because KLAS distinction is driven entirely by direct customer feedback, this recognition reflects the real-world performance, reliability, and impact of our platform in daily pathology practice.
KLAS Recognition as a Catalyst for What Comes Next Read More »
HALO AP 2.5 Sneak Peek Webinar
16 April 2026 | Learn about the exciting new features in the 2.5 versions of HALO AP®!
HALO AP 2.5 Sneak Peek Webinar Read More »
Masterclass: Unlock Cell Population Discovery Using HALO® High Dimensional Analysis
31 March 2026 | Learn how unbiased high-dimensional analysis can be seamlessly combined with AI-powered HALO workflows for multiplex images!
Masterclass: Unlock Cell Population Discovery Using HALO® High Dimensional Analysis Read More »
HALO AP® is Now Rated in Best in KLAS®: Earning ‘A’ Grades in All Categories
Albuquerque, NM, February 12, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced recognition by KLAS for top customer-rated performance in the European digital pathology market.
HALO AP® is Now Rated in Best in KLAS®: Earning ‘A’ Grades in All Categories Read More »
Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio
Albuquerque, NM, February 10, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the expansion of its macrodissection portfolio with the launch of Breast Macrodissect AI . The suite now includes advanced algorithms for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and breast cancer, with prostate cancer planned for release in early 2026.
Getting Started with HALO AI
5 March 2026 | Learn how to develop your own AI algorithms for segmentation, classification, and more using HALO AI
Getting Started with HALO AI Read More »
Indica Labs’ Frankfurt HALO® User Group Meeting 2026
17 March 2026 | Indica Labs is pleased to announce our Frankfurt HALO® User Group Meeting at The Hilton Frankfurt Airport on 17 March from 11:00 – 16:00.
Indica Labs’ Frankfurt HALO® User Group Meeting 2026 Read More »
Looking Back: Reviewing 2025 at Indica Labs
As we reach the end of 2025, the Indica Labs team extends our sincere thanks to the customers and collaborators who helped make this year one of remarkable innovation, growth, and scientific achievement.
Looking Back: Reviewing 2025 at Indica Labs Read More »
Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets
Albuquerque, NM, December 17, 2025 – Indica Labs, the global leader in AI-powered digital pathology, announced today that clinical revenue growth rate for HALO AP® is up 260% since 2023 and recurring revenue for 2025 shows a 200% increase year-over-year, reinforcing its position as a market leader in digital pathology diagnostics.
Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets Read More »